Author:
Ziranu Pina,Lai Eleonora,Schirripa Marta,Puzzoni Marco,Persano Mara,Pretta Andrea,Munari Giada,Liscia Nicole,Pusceddu Valeria,Loupakis Fotios,Demurtas Laura,Libertini Michela,Mariani Stefano,Migliari Marco,Dubois Marco,Giampieri Riccardo,Sotgiu Giovanni,Dei Tos Angelo Paolo,Lonardi Sara,Zaniboni Alberto,Fassan Matteo,Scartozzi Mario
Funder
Università degli Studi di Cagliari
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference88 articles.
1. Ceresa BP, Vanlandingham PA. Molecular mechanisms that regulate epidermal growth factor receptor inactivation. Clin Med Oncol. 2008;2:47–61.
2. Carpenter G. ErbB-4: mechanism of action and biology. Exp Cell Res. 2003;284:66–77.
3. Citri A, Skaria KB, Yarden Y. The deaf and dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res. 2003;284:54–65.
4. Yarden Y. The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001;37(Suppl. 4):S3-8.
5. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta. 2006;1766:120–39.